ArticleAnnals of translational medicine2021

Bupivacaine inhibits the malignant biological behavior of oral squamous cell carcinoma cells by inhibiting the activation of ERK1/2 and STAT3.

Zhongchao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.